Literature DB >> 15871581

Surgical-handling properties of the titanium prosthesis in ossiculoplasty.

Marcus M Maassen1, Hubert Löwenheim, Markus Pfister, Stephan Herberhold, Jesus Rodriguez Jorge, Ingo Baumann, Andreas Nüsser, Rainer Zimmermann, Sibylle Brosch, Hans P Zenner.   

Abstract

Despite the wide variety of ossiculoplasty techniques that are available, success rates are limited. Current use indicates that surgeons prefer ceramic, autograft bone, and plastic pore prostheses. During the past decade, titanium prostheses have been used with great promise. Although their use is not widespread, satisfaction rates are high. An earlier study of ossiculoplasty showed that titanium prostheses were effective in reducing conductive hearing loss. To date, the surgical-handling attributes of titanium middle ear prostheses have not been assessed. We report the results of our survey of 32 otologic surgeons who used the open Tübingen titanium prosthesis for primary and revision ossiculoplasty during tympanoplasty in 400 patients at 12 academic and nonacademic otolaryngology clinics, most of them in Germany. Because the audiometric efficacy of titanium prostheses has been previously reported, our primary outcomes measures included ease of use with respect to the amount of time required to prepare the implants for placement and the surgeons' overall impression of the intraoperative handling characteristics of the implants, taking into consideration factors such as positioning, length adjustment, visibility, and the stability of the coupling. Surgeons also compared the properties of the titanium implant with those of gold, ceramic, and autograft implants that they had used in the past. Based on the results of 383 of the 400 ossiculoplasties, our survey revealed that the titanium implant was significantly superior to the others in all measured respects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871581

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  8 in total

1.  Titanium prosthesis or autologous incus for total ossicular reconstruction in the absence of the stapes suprastructure and presence of mobile footplate.

Authors:  Abdulmajeed Zakzouk; Nicolas Bonmardion; Pierre Bouchetemble; Yannick Lerosey; Jean-Paul Marie
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-03       Impact factor: 2.503

2.  The efficiency of titanium middle ear prosthesis in ossicular chain reconstruction: our experience.

Authors:  Kshitij Dhaval Shah; Renuka A Bradoo; Anagha A Joshi; Deepti D Sapkale
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-03

3.  [Variable length titanium prostheses for type III tympanoplasty. Intraoperative length adjustment and fixation of the cartilage overlay].

Authors:  H-P Zenner; R Zimmermann; U Steinhardt; M M Maassen
Journal:  HNO       Date:  2006-04       Impact factor: 1.284

4.  Passive and active middle ear implants.

Authors:  Dirk Beutner; Karl-Bernd Hüttenbrink
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-03-10

5.  Biocompatible Nanocomposite Implant with Silver Nanoparticles for Otology-In Vivo Evaluation.

Authors:  Magdalena Ziąbka; Elżbieta Menaszek; Jacek Tarasiuk; Sebastian Wroński
Journal:  Nanomaterials (Basel)       Date:  2018-09-27       Impact factor: 5.076

Review 6.  Biocompatible Materials in Otorhinolaryngology and Their Antibacterial Properties.

Authors:  Jakub Spałek; Przemysław Ociepa; Piotr Deptuła; Ewelina Piktel; Tamara Daniluk; Grzegorz Król; Stanisław Góźdź; Robert Bucki; Sławomir Okła
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

7.  Titanium prostheses versus stapes columella type 3 tympanoplasty: a comparative prospective study.

Authors:  Fayez Bahmad; Andréa Gonçalves Perdigão
Journal:  Braz J Otorhinolaryngol       Date:  2020-09-14

8.  Middle Ear Prosthesis with Bactericidal Efficacy-In Vitro Investigation.

Authors:  Magdalena Ziąbka; Michał Dziadek; Elżbieta Menaszek; Rafał Banasiuk; Aleksandra Królicka
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.